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Introduction {#jah32207-sec-0004}
============

Cardiovascular disease (CVD) is responsible for 1 of every 3 deaths in the United States, with coronary heart disease (CHD) causing ≈1 of every 7 deaths.[1](#jah32207-bib-0001){ref-type="ref"} The estimated annual incidence of myocardial infarction (MI) is 660 000 new attacks, with an average age at first MI of 65.1 years for men and 72.0 years for women.[1](#jah32207-bib-0001){ref-type="ref"} Approximately 15% of those who experience an MI will die of it.[1](#jah32207-bib-0001){ref-type="ref"} Smoking cessation, regular physical activity (PA), and dietary changes may reduce mortality by 20% to 35% in MI survivors.[2](#jah32207-bib-0002){ref-type="ref"} Survival after an initial MI is increasing because of the success of secondary prevention programs and promotion of cardiac rehabilitation programs.[3](#jah32207-bib-0003){ref-type="ref"}, [4](#jah32207-bib-0004){ref-type="ref"}, [5](#jah32207-bib-0005){ref-type="ref"} Thus, MI survivors are a growing group and may be motivated to change their behavior to prevent future morbidity and mortality.

An estimated 5.8% of global CHD mortality is attributable to physical inactivity after accounting for other CVD risk factors.[6](#jah32207-bib-0006){ref-type="ref"}, [7](#jah32207-bib-0007){ref-type="ref"} The role of PA, sitting time, and incident CVD risk has been previously assessed in the WHI‐OS (Women\'s Health Initiative‐Observational Study) by Manson et al[8](#jah32207-bib-0008){ref-type="ref"} and Chomistek et al.[9](#jah32207-bib-0009){ref-type="ref"} These studies found that higher levels of PA (metabolic equivalent of task hours \[MET‐h\]/week) and lower amounts of prolonged sitting time were associated with a decreased risk of incident coronary events, but their analyses focused on women without past CVD. One previous study investigated change in PA after first MI in a population of 406 men and women from the Corpus Christi Heart Project cohort[10](#jah32207-bib-0010){ref-type="ref"} and found a reduction in all‐cause mortality for those who remained active, increased activity, or decreased activity post‐MI compared with those who were sedentary pre‐ and post‐MI. However, this study was relatively small and did not examine sitting time, which may be a distinct construct from lack of PA.[11](#jah32207-bib-0011){ref-type="ref"}

While there is substantial evidence that physical activity lowers risk of incident CVD, less is known on the benefits of PA for decreasing mortality post‐MI. Additionally, more research is needed on the potential effect of changing other lifestyle habits, such as sitting time, following an MI. Therefore, the purpose of the current study was to examine change in PA and sitting time among survivors of a first MI on all‐cause, CHD, and CVD mortality in the WHI‐OS.

Methods {#jah32207-sec-0005}
=======

Women\'s Health Initiative {#jah32207-sec-0006}
--------------------------

The goal of the WHI was to investigate major causes of morbidity and mortality in a nationally representative cohort of postmenopausal women. The WHI‐OS cohort included 93 676 postmenopausal women, aged 50 to 79 years at study entry, from 40 US clinical centers and enrolled between 1993 and 1998.[12](#jah32207-bib-0012){ref-type="ref"} Details on the reliability and measurement of baseline characteristics in the WHI have been previously published.[13](#jah32207-bib-0013){ref-type="ref"} All study sites obtained informed consent and institutional review board approval.

We identified 3129 women who experienced a first MI during follow‐up out of the original 93 676 women in the WHI‐OS. Nonfatal MI was confirmed based on standard diagnostic criteria for electrocardiography changes, elevated cardiac enzymes, or both.[14](#jah32207-bib-0014){ref-type="ref"} We then excluded 979 women with baseline prevalent CHD, stroke, or cancer, 61 women missing information on sitting or PA at baseline, and 89 women who reported they were unable to walk one block at baseline. Furthermore, 1144 women were excluded from the PA analysis because of MI occurring after the last measurement of PA and 1467 women were excluded from the sitting time analysis because of MI occurring after the last measurement of sitting time. Thus, 856 women were included in the PA analysis and 533 in the sitting‐time analysis.

Exposure Assessment {#jah32207-sec-0007}
-------------------

Baseline characteristics were self‐reported on questionnaires, including demographics, medical history, diet, smoking, and other lifestyle factors. Participants completed follow‐up assessments periodically after enrollment. The study protocol was approved by the institutional review board of each site, and all women provided written informed consent.

Recreational PA was self‐reported at baseline and annually through year 8 by detailed questionnaire. Information on walking frequency, duration, and pace, specifically outside of the home, was asked as well as information on other types of activity (mild, moderate, and strenuous). Examples of mild activity included slow dancing, bowling, and golf. Examples of moderate activity were biking outdoors, using an exercise machine, calisthenics, easy swimming, and popular or folk dancing. Examples of strenuous activity were aerobics, aerobic dancing, jogging, tennis, and swimming laps. Each type of activity was assigned an MET score on the basis of energy cost,[15](#jah32207-bib-0015){ref-type="ref"} and PA‐related energy expenditure (MET‐h/week) was calculated as the summed product of the frequency, duration, and intensity of the activity. A random sample of 536 participants had second measurements conducted on all PA ≈10 weeks after baseline. Test‐retest reliability for the PA variables was 0.53 to 0.72 with the intraclass correlation 0.77 for total PA.[16](#jah32207-bib-0016){ref-type="ref"}

Sitting time was assessed by questionnaire at baseline and twice during follow‐up (year 3 and year 6) with the following question: "During a usual day and night, about how many hours do you spend sitting? Be sure to include the time you spend sitting at work, sitting at the table eating, driving or riding in a car or bus, and sitting up watching TV or talking." Eight categories were provided for the response, ranging from less than 4 hours to 16 or more hours.

To represent long‐term exposure,[17](#jah32207-bib-0017){ref-type="ref"} the cumulative average for PA, sitting time, and walking was calculated from questionnaires at baseline, year 3 to year 8 for PA and walking and baseline, year 3, and year 6 for sitting time. Change in PA, walking, and sitting time were calculated as the difference between the cumulative average immediately following MI and the cumulative average immediately preceding MI. Thus, pre‐MI PA is the average of all measurements before the MI, and post‐MI PA is the average of all measurements after the MI. For physical activity, we used 7.5 MET‐h/week as the cut point, which is equivalent to accumulating 150 min/week of moderate‐intensity exercise, consistent with the current PA guidelines.[18](#jah32207-bib-0018){ref-type="ref"} Walking categories were determined based on the median of the data, with 3.5 MET‐h/week being equivalent to 1 h/day of brisk walking. Sitting‐time categories were determined based on previous research in the aging population[19](#jah32207-bib-0019){ref-type="ref"} using 8 h/day as the cut point. The 4 categories of change were: maintained low, decreased, increased, and maintained high. The cut points were as follows: PA, ≥7.5 MET‐h/week (high) versus \<7.5 MET‐h/week (low); walking, ≥3.5 MET‐h/week (high) versus \<3.5 MET‐h/week (low); and sitting time, ≥8 h/day (high) versus \<8 h/day (low).

Ascertainment of End Points {#jah32207-sec-0008}
---------------------------

The primary end points for this analysis were all‐cause, CHD, and CVD mortality. Underlying cause of death was identified through medical records, death certificates, and autopsy reports.[14](#jah32207-bib-0014){ref-type="ref"} Physicians blinded to the exposure information adjudicated the event. CHD and CVD mortality were confirmed through documentation on hospital or autopsy records of coronary disease or CVD was listed as the cause of death on death certificates.

Statistical Analysis {#jah32207-sec-0009}
--------------------

All analyses were performed using SAS statistical software (version 9.4; SAS Institute Inc, Cary, NC). Eligible participants contributed person‐time from return of the questionnaire immediately following first clinical MI to death from any cause, loss to follow‐up, or August 29, 2014, whichever occurred first. Baseline characteristics were compared according to categories of change in PA with a chi‐squared test for categorical variables and generalized linear model for continuous variables. We examined the association between pre‐ and post‐MI levels of PA, walking and sitting time, and risk of all‐cause, CHD, and CVD mortality using Cox proportional hazards models to estimate hazard ratios (HRs) and 95% CIs. The categories were: \>20, 7.5 to 20, 1.8 to 7.4, and ≤1.7 MET‐h/week for physical activity; ≥3.5 and \<3.5 MET‐h/week for walking; and ≤5, 5.1 to 7.9, and ≥8 h/day for sitting time.

We also examined the association between categories of change in PA, walking, and sitting time with risk of all‐cause, CHD, and CVD mortality using the 4 categories of change described above: maintained low, decreased, increased, and maintained high. Additionally, to further explore the association between change in PA, walking, and sitting time with all‐cause mortality, we assessed change in each exposure continuously, stratified by pre‐MI levels. Finally, conditional relative PA was calculated to express the relative PA change from pre‐MI to post‐MI, which was uncorrelated with PA pre‐MI, to estimate the independent contribution of PA change on mortality.[20](#jah32207-bib-0020){ref-type="ref"} Conditional relative PA was calculated as residuals by regressing post‐MI PA on pre‐MI PA.

Three models were used to evaluate the association between change in PA and sitting time after an MI and mortality. The first model was stratified by age only. The second model additionally included race, education, income, marital status, heart failure, cigarette smoking, family history of MI, alcohol consumption, Healthy Eating Index diet score, hours of sleep, depression, sitting time (for PA model), PA (for sitting time model), and vigorous PA (for walking model). The final model also adjusted for diabetes mellitus, hypertension, hyperlipidemia, body mass index, coronary artery bypass graft, and percutaneous transluminal coronary angioplasty. To account for potential bias attributed to severity of MI, in addition to adjusting for heart failure, we conducted a sensitivity analysis by excluding women who died within 2 years of MI and compared with the original analysis.

Results {#jah32207-sec-0010}
=======

Baseline characteristics according to category of change in PA are presented in Table [1](#jah32207-tbl-0001){ref-type="table-wrap"}. Women who maintained high PA pre‐MI and post‐MI were more likely to have attended college, be married, have a lower body mass index, and have an overall healthier diet at baseline compared with women who maintained low PA pre‐ and post‐MI.

###### 

Baseline Characteristics According to Change in PA Among Postmenopausal Women Who Survived an MI: WHI‐OS

  Change in Physical Activity Levels                        *P* Value                                               
  --------------------------------------------------------- ------------- ------------- ------------- ------------- ---------
  No. of participants                                       296           123           111           326           
  Age, y                                                    67.9 (6.8)    67.9 (7.0)    64.8 (6.8)    67.3 (6.6)    0.07
  PA, MET‐h/week                                            3.4 (4.5)     17.9 (11.1)   3.8 (3.7)     20.9 (14.8)   \<0.001
  Sitting time, h/day                                       7.7 (3.3)     7.1 (3.3)     7.7 (3.1)     7.0 (3.1)     0.02
  Race, %                                                                                                           0.81
  White                                                     89            90            91            91            
  Black                                                     8             1             1             2             
  Hispanic/Latino                                           1             2             1             2             
  Other                                                     2             2             2             2             
  Smoking status, %                                                                                                 0.02
  Never                                                     45            45            41            48            
  Past                                                      43            47            47            47            
  Current                                                   12            8             13            4             
  Age at menopause, y                                       47.8 (6.6)    46.5 (7.0)    46.9 (7.1)    48.2 (6.9)    \<0.40
  Alcohol, drinks/week                                      1.4 (3.1)     1.8 (3.2)     2.1 (3.8)     2.5 (5.0)     \<0.001
  Education, %                                                                                                      \<0.001
  High School                                               35            25            35            17            
  Vocational                                                11            12            15            11            
  College                                                   53            62            50            71            
  Income, %                                                                                                         \<0.001
  \<20 000                                                  25            31            17            11            
  20 000 to 74 999                                          61            54            65            65            
  \>75 000                                                  6             5             10            16            
  Marital status, %                                                                                                 \<0.01
  Yes                                                       53            46            66            60            
  No                                                        48            54            34            40            
  HRT use ever, %                                           50            48            59            61            \<0.01
  Waist‐to‐hip ratio                                        0.83 (0.08)   0.83 (0.09)   0.83 (0.07)   0.81 (0.07)   \<0.001
  Body mass index                                           29.5 (7.0)    28.1 (6.5)    29.1 (6.1)    26.4 (4.3)    \<0.001
  Depression, %                                             12            13            9             8             0.09
  Family history of MI, %                                   50            53            58            54            0.57
  CABG, %                                                   7             4             3             5             0.31
  PTCA, %                                                   6             7             1             4             0.09
  Hx of diabetes mellitus, %                                19            13            12            9             \<0.01
  Hx hypertension, %                                        58            50            51            47            0.05
  Hx hyperlipidemia, %                                      25            26            20            25            0.75
  HEI diet quality                                          65.8 (11.5)   69.5 (10.1)   67.5 (11.7)   71.9 (9.9)    \<0.001
  Sleep, h/day                                              8.0 (2.4)     8.2 (2.8)     8.2 (2.1)     8.2 (2.3)     0.28
  Heart failure[a](#jah32207-note-0003){ref-type="fn"}, %   13            13            10            10            0.57

CABG indicates coronary artery bypass grafting; HEI, Healthy Eating Index; HRT, hormone replacement therapy; Hx, history; MET‐h, metabolic equivalent of task hours; MI, myocardial infarction; PA, physical activity; PTCA, percutaneous transluminal coronary angioplasty; WHI‐OS, Women\'s Health Initiative‐Observational Study.

Heart failure that occurred during follow‐up.

During a median follow‐up of 7.2 years, 265 of the 856 women included in the PA analysis and 225 of the 533 women included in the sitting‐time analysis died. In multivariable‐adjusted analyses, PA pre‐ and post‐MI was inversely associated with all‐cause and CVD mortality (Table [2](#jah32207-tbl-0002){ref-type="table-wrap"}). Compared with women who reported \>20 MET‐h/week of PA pre‐MI, women with ≤1.7 MET‐h/week pre‐MI had an HR of 1.61 (95% CI, 1.00, 2.60; *P* for trend, \<0.01) for all‐cause mortality and 3.29 (95% CI, 2.03--5.33) for post‐MI PA ≤1.7 MET‐h/week. Similarly, for CVD mortality, women with ≤1.7 MET‐h/week pre‐MI had a HR of 2.00 (95% CI, 0.92, 4.34; *P* for trend=0.02) and 3.69 (95% CI, 1.61--8.47; *P* for trend, 0.001) for post‐MI PA compared with women reporting \>20 MET‐h/week. Walking \<3.5 MET‐h/week compared with ≥3.5 MET‐h/week pre‐MI was associated with an increased risk of all‐cause mortality (HR=1.44; 95% CI, 1.02--2.03; *P* for trend=0.04).

###### 

HRs and 95% CIs for All‐Cause, CHD, and CVD Mortality in Relation to Categories of Pre‐ and Post‐MI PA, Sitting Time, and Walking[a](#jah32207-note-0005){ref-type="fn"}

                        PA (MET‐h/week)   Sitting Time (h/day)   Walking (MET‐h/week)                                                                                               
  --------------------- ----------------- ---------------------- ---------------------- --------------- --------- ------ -------------- -------------- ------ ------ -------------- ------
  All‐cause mortality                                                                                                                                                               
  Person‐years          2062              3895                   3321                   1838                      1761   2862           2358                  4063   6150           
  No. of deaths         39                82                     93                     61                        36     74             56                    78     172            
  Pre‐MI, HR            1.00              1.31                   1.78                   1.46            0.02      1.00   0.93           0.90           0.75   1.00   1.44           0.04
  95% CI                                  0.86 to 2.00           1.15 to 2.74           0.91 to 2.35                     0.58 to 1.49   0.53 to 1.53                 1.02 to 2.03   
  Person‐years          1937              4114                   2855                   2210                      2774   1652           2555                  3382   6830           
  No. of deaths         32                72                     72                     99                        58     33             75                    64     186            
  Post‐MI, HR           1.00              1.16                   1.55                   3.29            \<0.001   1.00   1.10           1.29           0.26   1.00   1.37           0.09
  95% CI                                  0.73 to 1.84           0.96 to 2.49           2.03 to 5.33                     0.66 to 1.82   0.83 to 1.99                 0.95 to 1.98   
  CHD mortality                                                                                                                                                                     
  No. of deaths         10                17                     27                     10                        7      21             13                    16     42             
  Pre‐MI, HR            1.00              0.75                   2.07                   1.10            0.27      1.00   0.72           0.74           0.76   1.00   2.03           0.12
  95% CI                                  0.29 to 1.95           0.82 to 5.24           0.36 to 3.41                     0.18 to 2.97   0.17 to 3.22                 0.84 to 4.90   
  No. of deaths         5                 17                     18                     24                        16     9              16                    10     48             
  Post‐MI, HR           1.00              2.54                   5.44                   8.80            \<0.001   1.00   2.15           1.59           0.58   1.00   2.42           0.08
  95% CI                                  0.64 to 10.09          1.37 to 21.68          2.12 to 36.68                    0.62 to 7.52   0.46 to 5.50                 0.91 to 6.43   
  CVD mortality                                                                                                                                                                     
  No. of deaths         15                32                     46                     27                        17     36             22                    33     75             
  Pre‐MI, HR            1.00              1.17                   2.04                   1.74            0.04      1.00   0.68           0.77           0.62   1.00   1.39           0.22
  95% CI                                  0.59 to 2.33           1.05 to 3.98           0.82 to 6.69                     0.33 to 1.42   0.33 to 1.76                 0.82 to 2.34   
  No. of deaths         11                33                     32                     44                        26     17             32                    22     86             
  Post‐MI, HR           1.00              1.61                   2.40                   3.69            0.001     1.00   1.27           1.49           0.31   1.00   1.79           0.05
  95% CI                                  0.72 to 3.56           1.07 to 5.39           1.61 to 8.47                     0.60 to 2.71   0.71 to 3.10                 1.00 to 3.22   

CHD indicates coronary heart disease; CVD, cardiovascular disease; HR, hazard ratio; MET‐h, metabolic equivalent of task hours; MI, myocardial infarction; PA, physical activity.

Adjusted for age (stratified), education, race, income (updated), marital status (updated), hormone replacement therapy use, physical function, congestive heart failure (updated), depression, family history MI, cigarette smoking (updated), sleep, alcohol drinks per week, age at menopause, Healthy Eating Index 2005, PA (sitting time), sitting time (PA), vigorous PA (walking), high cholesterol requiring pills, coronary artery bypass grafting, percutaneous transluminal coronary angioplasty, hypertension, diabetes mellitus, and body mass index.

Means and SDs of PA pre‐ and post‐MI by categories of change in PA are presented in Table [S1](#jah32207-sup-0001){ref-type="supplementary-material"}. The average weekly PA for those who decreased PA was 15.33±7.87 MET‐h/week pre‐MI and 3.01±2.44 MET‐h/week post‐MI. For those who increased PA, average weekly PA was 3.47±2.34 MET‐h/week pre‐MI and 14.47±7.32 MET‐h/week post‐MI. Age and multivariable‐adjusted HRs for all‐cause, CHD, and CVD mortality by categories of change in PA, sitting time, and walking are presented in Table [3](#jah32207-tbl-0003){ref-type="table-wrap"}. Using maintained low PA as the reference group, the HRs for all‐cause mortality for women who increased PA and maintained high PA were 0.54 (95% CI, 0.34--0.82) and 0.52 (95% CI, 0.36--0.73), respectively. Again, using maintained low PA as the reference group, the HRs for CHD and CVD mortality for women who maintained high PA were 0.26 (95% CI, 0.11--0.60) and 0.41 (95% CI, 0.24--0.71), respectively. When we investigated walking specifically, the all‐cause mortality HR for women who maintained high walking was 0.65 (95% CI, 0.42--0.99), compared with women who maintained low walking pre‐ and post‐MI. Change in sitting time as a categorical variable was not significantly associated with all‐cause, CHD, or CVD mortality.

###### 

All‐Cause, CHD, and CVD Mortality by Change in PA, Sitting Time, and Walking After First MI: WHI‐OS

                                                                   Deaths   Unadjusted Rates, Per 1000 Person‐Years   Age‐Adjusted        Multivariable‐Adjusted[a](#jah32207-note-0007){ref-type="fn"}   Fully Adjusted[b](#jah32207-note-0008){ref-type="fn"}
  ---------------------------------------------------------------- -------- ----------------------------------------- ------------------- --------------------------------------------------------------- -------------------------------------------------------
  PA                                                                                                                                                                                                      
  All‐cause mortality                                                                                                                                                                                     
  Maintained low PA[c](#jah32207-note-0009){ref-type="fn"}         125      415                                       1.00                1.00                                                            1.00
  Decreased PA[d](#jah32207-note-0010){ref-type="fn"}              44       271                                       0.89 (0.62--1.29)   0.96 (0.65--1.44)                                               0.99 (0.66--1.48)
  Increased PA[e](#jah32207-note-0011){ref-type="fn"}              27       233                                       0.45 (0.29--0.69)   0.52 (0.33--0.82)                                               0.54 (0.34--0.86)
  Maintained high PA[f](#jah32207-note-0012){ref-type="fn"}        79       265                                       0.41 (0.31--0.55)   0.51 (0.36--0.72)                                               0.52 (0.36--0.73)
  CHD mortality                                                                                                                                                                                           
  Maintained low PA                                                31       111                                       1.00                1.00                                                            1.00
  Decreased PA                                                     11       76                                        0.90 (0.42--1.92)   0.65 (0.27--1.58)                                               0.84 (0.34--2.10)
  Increased PA                                                     6        33                                        0.46 (0.19--1.12)   0.41 (0.15--1.12)                                               0.39 (0.13--1.15)
  Maintained high PA                                               16       57                                        0.31 (0.16--0.60)   0.29 (0.13--0.64)                                               0.26 (0.11--0.60)
  CVD mortality                                                                                                                                                                                           
  Maintained low PA                                                58       203                                       1.00                1.00                                                            1.00
  Decreased PA                                                     18       102                                       0.78 (0.44--1.37)   0.81 (0.43--1.52)                                               0.82 (0.44--1.55)
  Increased PA                                                     14       92                                        0.55 (0.30--1.00)   0.61 (0.32--1.16)                                               0.59 (0.30--1.15)
  Maintained high PA                                               30       109                                       0.34 (0.21--0.54)   0.43 (0.25--0.74)                                               0.41 (0.24--0.71)
  Sitting time                                                                                                                                                                                            
  All‐cause mortality                                                                                                                                                                                     
  Maintained high sitting[g](#jah32207-note-0013){ref-type="fn"}   46       350                                       1.00                1.00                                                            1.00
  Increased sitting[h](#jah32207-note-0014){ref-type="fn"}         29       427                                       1.32 (0.80--2.18)   1.52 (0.87--2.66)                                               1.46 (0.81--2.65)
  Decreased sitting[i](#jah32207-note-0015){ref-type="fn"}         32       316                                       0.89 (0.56--1.42)   1.02 (0.60--1.74)                                               1.13 (0.65--1.99)
  Maintained low sitting[j](#jah32207-note-0016){ref-type="fn"}    58       258                                       0.67 (0.44--1.02)   0.84 (0.52--1.36)                                               0.86 (0.51--1.45)
  CHD mortality                                                                                                                                                                                           
  Maintained high sitting                                          11       81                                        1.00                1.00                                                            1.00
  Increased sitting                                                5        101                                       0.80 (0.25--2.58)   1.46 (0.35--6.05)                                               2.37 (0.41--13.75)
  Decreased sitting                                                11       63                                        1.26 (0.53--2.99)   1.52 (0.50--4.59)                                               1.47 (0.32--6.73)
  Maintained low sitting                                           13       76                                        0.45 (0.19--1.06)   6.65 (0.20--2.11)                                               0.60 (0.18--2.81)
  CVD mortality                                                                                                                                                                                           
  Maintained high sitting                                          20       138                                       1.00                1.00                                                            1.00
  Increased sitting                                                12       202                                       1.25 (0.58--2.70)   1.37 (0.56--3.38)                                               1.55 (0.58--4.11)
  Decreased sitting                                                15       139                                       0.95 (0.47--1.89)   1.10 (0.49--2.46)                                               1.05 (0.43--2.57)
  Maintained low sitting                                           27       129                                       0.62 (0.33--1.15)   0.75 (0.35--1.57)                                               0.70 (0.30--1.64)
  Walking                                                                                                                                                                                                 
  All‐cause mortality                                                                                                                                                                                     
  Maintained low walking[k](#jah32207-note-0017){ref-type="fn"}    166      377                                       1.00                1.00                                                            1.00
  Decreased walking[l](#jah32207-note-0018){ref-type="fn"}         14       143                                       0.66 (0.43--1.02)   0.69 (0.44--1.10)                                               0.70 (0.42--1.07)
  Increased walking[m](#jah32207-note-0019){ref-type="fn"}         24       242                                       0.59 (0.34--1.04)   0.62 (0.34--1.14)                                               0.68 (0.37--1.27)
  Maintained high walking[n](#jah32207-note-0020){ref-type="fn"}   47       247                                       0.60 (0.42--0.87)   0.67 (0.45--1.01)                                               0.65 (0.42--0.99)
  CHD mortality                                                                                                                                                                                           
  Maintained low walking                                           45       102                                       1.00                1.00                                                            1.00
  Decreased walking                                                1        10                                        0.85 (0.39--1.89)   0.58 (0.23--1.45)                                               0.60 (0.21--1.70)
  Increased walking                                                4        40                                        0.29 (0.07--1.22)   0.32 (0.06--1.63)                                               0.44 (0.08--2.37)
  Maintained high walking                                          9        47                                        0.32 (0.12--0.82)   0.36 (0.11--1.00)                                               0.34 (0.10--1.14)
  CVD mortality                                                                                                                                                                                           
  Maintained low walking                                           79       180                                       1.00                1.00                                                            1.00
  Decreased walking                                                5        51                                        0.80 (0.44--1.47)   0.78 (0.41--1.50)                                               0.77 (0.39--1.51)
  Increased walking                                                8        80                                        0.35 (0.12--0.97)   0.36 (0.12--1.08)                                               0.39 (0.12--1.22)
  Maintained high walking                                          17       89                                        0.52 (0.29--0.93)   0.62 (0.33--1.19)                                               0.57 (0.29--1.12)

CHD indicates coronary heart disease; CVD, cardiovascular disease; MI, myocardial infarction; PA, physical activity WHI‐OS, Women\'s Health Initiative‐Observational Study.

Adjusted for age, education, race, income (updated), marital status (updated), hormone replacement therapy use, physical function, congestive heart failure (updated), depression, family history MI, cigarette smoking (updated), sleep, alcohol drinks per week, age at menopause, Healthy Eating Index 2005, PA (sitting time), sitting time (PA), and vigorous PA (walking).

Multivariable‐adjusted model+high cholesterol requiring pills, coronary artery bypass grafting, percutaneous transluminal coronary angioplasty, hypertension, diabetes mellitus, and body mass index.

\<7.5 (metabolic equivalent of task hours/week), no change.

≥7.5 to \<7.5 (metabolic equivalent of task hours/week).

\<7.5 to ≥7.5 (metabolic equivalent of task hours/week).

≥7.5 (metabolic equivalent of task hours/week), no change.

≥8 (h/day), no change.

\<8 to ≥8 (h/day).

≥8 to \<8 (h/day).

\<8 (h/day), no change.

\<3.5 (metabolic equivalent of task hours/week), no change.

≥3.5 to \<3.5 (metabolic equivalent of task hours/week).

\<3.5 to ≥3.5 (metabolic equivalent of task hours/week).

≥3.5 (metabolic equivalent of task hours/week), no change.

We then examined continuous change in PA, sitting time, and walking, stratified by pre‐MI levels (Table [4](#jah32207-tbl-0004){ref-type="table-wrap"}). Among women who reported PA \<7.5 MET‐h/week pre‐MI, there was an 8% decreased risk (HR=0.92; 95% CI, 0.88, 0.96) of all‐cause mortality, 16% decreased risk of CHD mortality (HR=0.84; 95% CI, 0.76, 0.93), and 9% decreased risk of CVD mortality (HR=0.91; 95% CI, 0.86, 0.96) for a 1 MET‐h/week increase in PA. Among those women reporting PA ≥7.5 MET‐h/week pre‐MI, there was an 8% decreased risk of CHD mortality for a 1 MET‐h/week increase in PA. HRs for continuous change in PA were not statistically significant among women who reported PA levels that met the PA guidelines pre‐MI for all‐cause and CVD mortality. Women who had pre‐MI levels of sitting time \<8 h/day had a 9% higher risk (HR=1.09; 95% CI: 1.01, 1.19) of all‐cause mortality for every 1 h/day increase in sitting time. The HR for continuous change in sitting time was not statistically significant among women who reported sitting time \>8 h/day pre‐MI. Finally, results for walking were similar to that for PA, but stronger. Women who had pre‐MI levels of walking \<3.5 MET‐h/week had a 19% decreased risk of all‐cause mortality (HR=0.81; 95% CI, 0.72, 0.91), 35% decreased risk of CHD mortality (HR=0.65; 95% CI, 0.45--0.94), and 34% decreased risk of CVD mortality (HR=0.66; 95% CI, 0.52--0.83) for a 1 MET‐h/week increase in walking.

###### 

All‐Cause, CHD, and CVD Mortality in Relation to Continuous Change in PA, Sitting Time, and Walking Following MI, Stratified by Pre‐MI Levels of PA, Sitting Time, and Walking

                        Age‐Adjusted                                         Multivariable‐Adjusted[a](#jah32207-note-0022){ref-type="fn"}
  --------------------- ---------------------------------------------------- ---------------------------------------------------------------
  Pre‐MI PA             HR (95% CI) for a 1 MET‐h/week increase in PA        
  All‐cause mortality                                                        
  ≥7.5 MET‐h/week       0.98 (0.97--1.00)                                    0.99 (0.97--1.01)
  \<7.5 MET‐h/week      0.92 (0.89--0.96)                                    0.92 (0.88--0.96)
  CHD mortality                                                              
  ≥7.5 MET‐h/week       0.94 (0.90--0.97)                                    0.92 (0.87--0.98)
  \<7.5 MET‐h/week      0.88 (0.81--0.96)                                    0.84 (0.76--0.93)
  CVD mortality                                                              
  ≥7.5 MET‐h/week       0.98 (0.95--1.00)                                    0.98 (0.95--1.01)
  \<7.5 MET‐h/week      0.91 (0.87--0.96)                                    0.91 (0.86--0.96)
  Pre‐MI sitting time   HR (95% CI) for a 1 h/day increase in sitting time   
  All‐cause mortality                                                        
  ≥8 h/day              1.11 (0.99--1.24)                                    1.14 (0.97--1.35)
  \<8 h/day             1.11 (1.04--1.19)                                    1.09 (1.01--1.19)
  CHD mortality                                                              
  ≥8 h/day              1.08 (0.89--1.33)                                    1.16 (0.79--1.69)[b](#jah32207-note-0023){ref-type="fn"}
  \<8 h/day             1.01 (0.86--1.19)                                    1.05 (0.87--1.28)[b](#jah32207-note-0023){ref-type="fn"}
  CVD mortality                                                              
  ≥8 h/day              1.08 (0.92--1.28)                                    1.05 (0.62--1.79)[c](#jah32207-note-0024){ref-type="fn"}
  \<8 h/day             1.13 (0.99--1.22)                                    1.07 (0.94--1.21)
  Pre‐MI walking        HR (95% CI) for a 1 MET‐h/week increase in walking   
  All‐cause mortality                                                        
  ≥3.5 MET‐h/week       1.02 (0.96--1.08)                                    1.03 (0.95--1.11)
  \<3.5 MET‐h/week      0.85 (0.77--0.94)                                    0.81 (0.72--0.91)
  CHD mortality                                                              
  ≥3.5 MET‐h/week       1.05 (0.94--1.18)                                    1.17 (0.85--1.60)[c](#jah32207-note-0024){ref-type="fn"}
  \<3.5 MET‐h/week      0.68 (0.53--0.88)                                    0.65 (0.45--0.94)
  CVD mortality                                                              
  ≥3.5 MET‐h/week       1.06 (0.97--1.16)                                    1.05 (0.93--1.23)
  \<3.5 MET‐h/week      0.73 (0.61--0.87)                                    0.66 (0.52--0.83)

CHD indicates coronary heart disease; CVD, cardiovascular disease; HR, hazard ratio; MET‐h, metabolic equivalent of task hours; MI, myocardial infarction; PA, physical activity.

Adjusted for age, education, race, income (updated), marital status (updated), hormone replacement therapy use, physical function, congestive heart failure (updated), depression, family history MI, cigarette smoking (updated), sleep, alcohol drinks per week, age at menopause, Healthy Eating Index 2005, PA (sitting time), sitting time (PA), and vigorous PA (walking).

Because of model convergence criterion, we used a reduced model: adjusted for age, education, race, physical function, congestive heart failure (updated), cigarette smoking (updated), and PA (sitting time).

model convergence criterion, we used a reduced model: adjusted for age, education, race, income (updated), marital status (updated), hormone replacement therapy use, physical function, congestive heart failure (updated), depression, family history MI, cigarette smoking (updated), age at menopause, Healthy Eating Index 2005, and vigorous PA (walking).

Similar results were found when conditional relative PA was assessed in relation to all‐cause, CHD, and CVD mortality in both age‐ and multivariate‐adjusted models (Table [S2](#jah32207-sup-0001){ref-type="supplementary-material"}). After excluding women who died within the first 2 years post‐MI, the results were similar.

Discussion {#jah32207-sec-0011}
==========

In this prospective study of postmenopausal MI survivors in the United States, maintaining at least 7.5 MET‐h/week of PA pre‐ to post‐MI was associated with lower risk of all‐cause, CHD, and CVD mortality. Additionally, individuals who increased PA after a first MI had a lower risk of all‐cause mortality compared with women who maintained low PA. Finally, when examined continuously, increased sitting time post‐MI was associated with an increased risk of all‐cause mortality among individuals with low sitting time (\<8 h/day) pre‐MI.

Only 1 study to date has examined the association between change in PA after a first MI.[10](#jah32207-bib-0010){ref-type="ref"} Thus, the current analysis, which assesses the association between change in PA, sitting time, and walking and all‐cause, CHD, and CVD mortality provides a significant contribution to the current literature. Our results are consistent with a recent study that found[10](#jah32207-bib-0010){ref-type="ref"} lower risk of all‐cause mortality in individuals who maintained high PA, or increased PA after a first MI compared with those who maintained low PA pre‐ and post‐MI. Although the earlier study included both men and women, the number of women was small (150) and the instrument used to measure PA was not validated. Moreover, sitting time was not considered a separate construct from physical inactivity in the analysis and walking was not examined in addition to total PA. We extend this research by examining the association of change in sitting time and PA with mortality as independent entities in postmenopausal women. Additionally, by using the cumulative average of PA, sitting time, and walking pre‐ and post‐MI, we were able to capture long‐term exposure.[17](#jah32207-bib-0017){ref-type="ref"} Because of the timing and frequency of the exposure measurements throughout the study, using cumulative average is more representative of long‐term exposure for PA and walking, but not necessarily for sitting time, because it was only assessed 3 times throughout follow‐up.

When examined categorically, change in sitting time was not associated with mortality in the main analysis. However, when examined continuously, we did observe an increased risk of all‐cause mortality for every 1‐h/day increase in sitting time in those women who sat for 8 or less hours/day pre‐MI. Our study is the first population‐based study to investigate change in sitting time after a first MI.

Several mechanisms may explain why our results were stronger for CVD mortality compared to all‐cause mortality. Prolonged sitting has been associated with increased total cholesterol, triglycerides, waist circumference, decreased glucose uptake, and decreased skeletal muscle lipoprotein lipase activity.[21](#jah32207-bib-0021){ref-type="ref"}, [22](#jah32207-bib-0022){ref-type="ref"}, [23](#jah32207-bib-0023){ref-type="ref"} Previous research has shown that repeated bouts of prolonged sitting result in low shear rates leading to endothelial dysfunction, which has also been linked to vascular mortality.[24](#jah32207-bib-0024){ref-type="ref"} Breaking up sitting time with light PA has been shown to counteract the adverse effects on the endothelium.[24](#jah32207-bib-0024){ref-type="ref"} Last, increased lifestyle PA, including walking, post‐MI has been associated with improvement in cardiorespiratory fitness,[25](#jah32207-bib-0025){ref-type="ref"} which has been shown to have prognostic benefit even in patients with reduced left ventricular ejection fraction.[26](#jah32207-bib-0026){ref-type="ref"}

A potential source of bias could be that individuals did not increase their PA or decrease their sitting time because of the severity of their first MI. Unfortunately, we did not have information on MI severity; however, we did exclude women unable to walk at least 1 block and controlled for congestive heart failure, which was updated throughout the study within our multivariate models in an attempt to adjust for severity. We also conducted a sensitivity analysis excluding women who died within 2 years of their MI, and results were similar to our main analysis. When excluding 47 women who died within 2 years of their MI, the HRs in the fully adjusted model for all‐cause mortality in women who maintained high PA was 0.55 (95% CI, 0.37--0.81), compared with women who maintained low PA. Additionally, the women excluded from the analysis for missing or inadequate data did not differ from those included in the analysis on baseline PA, baseline sitting time, age, smoking status, body mass index, or Healthy Eating Index diet quality.

Our study had several strengths, including its prospective design, the large multiethnic cohort of postmenopausal women, wide variety of information on covariates, and detailed longitudinal information on PA and sitting time. This is the first study to investigate the association of change in sitting time and walking after a first MI and subsequent mortality.

The limitations of the present study include some aspects of exposure assessment. First, sitting time was measured only at baseline, year 3, and year 6. More‐frequent ascertainment of sitting time would have provided estimates of sitting times more proximal to time of MI; we were unable to examine changes in sitting time that occurred more frequently than our measurement timing. Additionally, both PA and sitting time were self‐reported. Nonetheless, the PA measurement has been validated in this cohort,[27](#jah32207-bib-0027){ref-type="ref"} and measurement error is likely to be nondifferential because of the prospective nature of the study. Accelerometers could provide more‐accurate measurements of sitting time and PA.[28](#jah32207-bib-0028){ref-type="ref"} The results of this study are applicable only to postmenopausal women and may not be generalizable to younger women, populations with a different distribution of race/ethnicity, or men. Additionally, there are a small number of deaths in some of the categories. Finally, as with any observational study, residual confounding by other lifestyle factors should be taken into consideration.

With the improvement in medical care, there are increasing numbers of MI survivors,[9](#jah32207-bib-0009){ref-type="ref"} a group of individuals who may be highly motivated to make lifestyle changes. Thus, the present study has important public health implications, particularly given the high prevalence of prolonged sitting time and PA in the population. The results of the current study suggest that women who survive an initial MI should limit sedentary time and increase PA, such as walking, to decrease subsequent mortality. However, we encourage women with a history of MI to consult with their physician before increasing PA to ensure that it is safe for them to do so.
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**Table S1.** Means and SDs of Physical Activity (PA) Pre‐ and Post‐Myocardial Infarction (MI) in MET‐h/week by Categories of Change in PA

**Table S2.** Hazard Ratios (HR) and 95% CI for All‐Cause, Coronary Heart Disease (CHD), and Cardiovascular Disease (CVD) Mortality in Relation to Conditional Relative Physical Activity
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Click here for additional data file.
